Provider: Nature Publishing Group
Content: application/x-research-info-systems
TY  - JOUR
AU  - Hewitt, H B
AU  - Blake, E R
AU  - Walder, A S
TI  - A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin
JO  - Br. J. Cancer
PY  - 1976///
VL  - 33
SP  - 241
EP  - 241
ER  - 

TY  - JOUR
AU  - Woglom, W H
TI  - Immunity to transplantable tumors
JO  - Cancer Res.
PY  - 1929///
VL  - 4
SP  - 129
EP  - 129
ER  - 

TY  - GEN
AU  - Rosenberg, S A
TI  - Principles and Practice of the Biologic Therapy of Cancer
PY  - 2000///
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
JO  - N. Engl. J. Med.
PY  - 1985///
VL  - 313
SP  - 1485
EP  - 1492
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
AU  - Yang, J C
AU  - White, D E
AU  - Steinberg, S M
TI  - Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2
JO  - Ann. Surg.
PY  - 1998///
VL  - 228
SP  - 307
EP  - 319
ER  - 

TY  - JOUR
AU  - Fyfe, G
TI  - Results of treatment of 255 patients with metastatic renal cell carcinoma who received high dose proleukin interleukin-2 therapy
JO  - J. Clin. Oncol.
PY  - 1995///
VL  - 13
SP  - 688
EP  - 696
ER  - 

TY  - JOUR
AU  - Atkins, M B
TI  - High-dose recombinant interleukin-2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993
JO  - J. Clin. Oncol.
PY  - 1999///
VL  - 17
SP  - 2105
EP  - 2116
ER  - 

TY  - JOUR
AU  - Rosenberg, S
TI  - A. A new era for cancer immunotherapy based on the genes that encode cancer antigens
JO  - Immunity
PY  - 1999///
VL  - 10
SP  - 281
EP  - 287
ER  - 

TY  - JOUR
AU  - Boon, T
AU  - Coulie, P G
AU  - Van den Eynde, B
TI  - Tumor antigens recognized by T cells
JO  - Immunol. Today
PY  - 1997///
VL  - 18
SP  - 267
EP  - 268
ER  - 

TY  - JOUR
AU  - Hunt, D F
TI  - Characterization of peptides bound to the Class I MHC molecule HLA-A2.1 by mass spectrometry
JO  - Science
PY  - 1992///
VL  - 255
SP  - 1261
EP  - 1263
ER  - 

TY  - JOUR
AU  - Cox, A L
TI  - Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
JO  - Science
PY  - 1994///
VL  - 264
SP  - 716
EP  - 719
ER  - 

TY  - JOUR
AU  - Kawashima, I
AU  - Hudson, S J
AU  - Tsai, V
TI  - The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors
JO  - Hum. Immunol.
PY  - 1989///
VL  - 59
SP  - 1
EP  - 14
ER  - 

TY  - JOUR
AU  - Chen, Y T
AU  - Scanlan, M J
AU  - Sahin, U
TI  - A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
JO  - Proc. Natl Acad. Sci. USA
PY  - 1997///
VL  - 94
SP  - 1914
EP  - 1918
ER  - 

TY  - JOUR
AU  - Wang, R -F
AU  - Wang, X
AU  - Atwood, A L
AU  - Topalian, S L
AU  - Rosenberg, S A
TI  - Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen
JO  - Science
PY  - 1999///
VL  - 284
SP  - 1351
EP  - 1354
ER  - 

TY  - GEN
AU  - Lowy, D R
AU  - Schiller, J T
TI  - Cancer Principles & Practice of Oncology
PY  - 2001///
ER  - 

TY  - JOUR
AU  - Stoler, D L
TI  - The onset and extend of genomic instability in sporadic colorectal tumor progression
JO  - Proc. Natl Acad. Sci. USA
PY  - 1999///
VL  - 26
SP  - 15121
EP  - 15126
ER  - 

TY  - JOUR
AU  - Landsteiner, K
AU  - Chase, M W
TI  - Experiments on transfer of cutaneous sensitivity to simple compounds
JO  - Proc. Soc. Exp. Biol. Med.
PY  - 1942///
VL  - 49
SP  - 
EP  - 
ER  - 

TY  - JOUR
AU  - Klein, E
AU  - Sjogren, H O
TI  - Humoral and cellular factors in homograft and isograft immunity
JO  - Cancer Res.
PY  - 1960///
VL  - 20
SP  - 
EP  - 
ER  - 

TY  - JOUR
AU  - Old, L J
AU  - Boyse, E A
AU  - Clarke, D A
TI  - Antigenic properties of chemically induced tumors
JO  - Ann. NY Acad. Sci.
PY  - 1962///
VL  - 101
SP  - 80
EP  - 80
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone
JO  - N. Engl. J. Med.
PY  - 1987///
VL  - 316
SP  - 889
EP  - 897
ER  - 

TY  - JOUR
AU  - Muul, L M
AU  - Spiess, P J
AU  - Director, E P
AU  - Rosenberg, S A
TI  - Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma
JO  - J. Immunol.
PY  - 1987///
VL  - 138
SP  - 989
EP  - 995
ER  - 

TY  - JOUR
AU  - Itoh, K
AU  - Platsoucas, D C
AU  - Balch, C M
TI  - Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas: activation by interleukin 2 and autologous tumor cells and involvement of the T cell receptor
JO  - J. Exp. Med.
PY  - 1988///
VL  - 168
SP  - 1419
EP  - 1441
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report
JO  - N. Engl. J. Med.
PY  - 1988///
VL  - 319
SP  - 1676
EP  - 1680
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and interleukin-2
JO  - J. Natl Cancer Inst.
PY  - 1994///
VL  - 86
SP  - 1159
EP  - 1166
ER  - 

TY  - JOUR
AU  - Papadopoulos, E B
TI  - Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
JO  - N. Engl. J. Med.
PY  - 1994///
VL  - 17
SP  - 1185
EP  - 1191
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma
JO  - Nature Med.
PY  - 1998///
VL  - 4
SP  - 321
EP  - 327
ER  - 

TY  - JOUR
AU  - Walter, E A
TI  - Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
JO  - N. Engl. J. Med.
PY  - 1995///
VL  - 333
SP  - 1038
EP  - 1044
ER  - 

TY  - JOUR
AU  - Yee, C
AU  - Gilbert, M J
AU  - Riddell, S R
TI  - Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus
JO  - J. Immunol.
PY  - 1996///
VL  - 157
SP  - 4079
EP  - 4086
ER  - 

TY  - JOUR
AU  - Dudley, M E
AU  - Ngo, L T
AU  - Westwood, J
AU  - Wunderlich, J R
AU  - Rosenberg, S A
TI  - T cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes
JO  - Cancer J. Sci. Am.
PY  - 2000///
VL  - 6
SP  - 69
EP  - 77
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Gene therapy for cancer
JO  - J. Am. Med. Assoc.
PY  - 1992///
VL  - 268
SP  - 2416
EP  - 2419
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
JO  - J. Natl Cancer. Inst.
PY  - 1998///
VL  - 90
SP  - 1894
EP  - 1900
ER  - 

TY  - JOUR
AU  - Marshall, J L
TI  - Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
JO  - J. Clin. Oncol.
PY  - 2000///
VL  - 23
SP  - 3963
EP  - 3973
ER  - 

TY  - JOUR
AU  - Eder, J P
TI  - A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer
JO  - Clin. Cancer Res.
PY  - 2000///
VL  - 5
SP  - 1632
EP  - 1638
ER  - 

TY  - JOUR
AU  - Marshall, J L
TI  - Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen
JO  - J. Clin. Oncol.
PY  - 1999///
VL  - 17
SP  - 332
EP  - 337
ER  - 

TY  - JOUR
AU  - Restifo, N P
AU  - Ying, H
AU  - Hwang, L
AU  - Leitner, W W
TI  - The promise of nucleic acid vaccines
JO  - Gene Ther.
PY  - 2000///
VL  - 2
SP  - 89
EP  - 92
ER  - 

TY  - JOUR
AU  - Wang, R
TI  - Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
JO  - Science
PY  - 1998///
VL  - 282
SP  - 476
EP  - 480
ER  - 

TY  - GEN
AU  - Dallal, R M
AU  - Mailliard, R
AU  - Lotze, M T
TI  - Principles and Practice of the Biologic Therapy of Cancer
PY  - 2000///
ER  - 

TY  - JOUR
AU  - Gong, J
TI  - Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
JO  - J. Immunol.
PY  - 2000///
VL  - 3
SP  - 1705
EP  - 1711
ER  - 

TY  - JOUR
AU  - Parkhurst, M R
TI  - Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A[ast] 0210 binding residues
JO  - J. Immunol.
PY  - 1996///
VL  - 157
SP  - 2539
EP  - 2548
ER  - 

TY  - JOUR
AU  - Rosenberg, S A
TI  - Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine
JO  - J. Immunol.
PY  - 1999///
VL  - 163
SP  - 1690
EP  - 1695
ER  - 

TY  - GEN
AU  - Marincola, F M
TI  - Principles and Practice of the Biologic Therapy of Cancer
PY  - 2000///
ER  - 

TY  - JOUR
AU  - Kawakami, Y
TI  - Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
JO  - Proc. Natl Acad. Sci. USA
PY  - 1994///
VL  - 91
SP  - 3515
EP  - 3519
ER  - 

TY  - JOUR
AU  - Kawakami, Y
TI  - Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection
JO  - Proc. Natl Acad. Sci. USA
PY  - 1994///
VL  - 91
SP  - 6458
EP  - 6462
ER  - 

TY  - JOUR
AU  - Brichard, V
TI  - The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
JO  - J. Exp. Med.
PY  - 1993///
VL  - 178
SP  - 489
EP  - 495
ER  - 

TY  - JOUR
AU  - Wang, R F
AU  - Robbins, P F
AU  - Kawakami, Y
AU  - Kang, X Q
AU  - Rosenberg, S A
TI  - Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes
JO  - J. Exp. Med.
PY  - 1995///
VL  - 181
SP  - 799
EP  - 804
ER  - 

TY  - JOUR
AU  - Wang, R -F
AU  - Appella, E
AU  - Kawakami, Y
AU  - Kang, X
AU  - Rosenberg, S A
TI  - Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
JO  - J. Exp. Med.
PY  - 1996///
VL  - 184
SP  - 2207
EP  - 2216
ER  - 

TY  - JOUR
AU  - Salazar-Onfray, F
TI  - Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells
JO  - Cancer Res.
PY  - 1997///
VL  - 57
SP  - 4348
EP  - 4355
ER  - 

TY  - JOUR
AU  - Van der Bruggen, P
TI  - A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
JO  - Science
PY  - 1991///
VL  - 254
SP  - 1643
EP  - 1647
ER  - 

TY  - JOUR
AU  - Visseren, M J
TI  - Identification of HLA-A[ast]0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product
JO  - Int. J. Cancer
PY  - 1997///
VL  - 73
SP  - 125
EP  - 130
ER  - 

TY  - JOUR
AU  - Gaugler, B
TI  - Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
JO  - J. Exp. Med.
PY  - 1994///
VL  - 179
SP  - 921
EP  - 930
ER  - 

TY  - JOUR
AU  - Panelli, M C
TI  - A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12
JO  - J. Immunol.
PY  - 2000///
SP  - 4382
EP  - 4392
ER  - 

TY  - JOUR
AU  - Boel, P
TI  - BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
JO  - Immunity
PY  - 1995///
VL  - 2
SP  - 167
EP  - 175
ER  - 

TY  - JOUR
AU  - Van Den Eynde, B
TI  - A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
JO  - J. Exp. Med.
PY  - 1995///
VL  - 182
SP  - 689
EP  - 698
ER  - 

TY  - JOUR
AU  - Jager, E
AU  - Chen, Y T
AU  - Drijfhout, J W
TI  - Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
JO  - J. Exp. Med.
PY  - 1998///
VL  - 187
SP  - 265
EP  - 270
ER  - 

TY  - JOUR
AU  - Wang, R -F
TI  - A breast and melanoma-shared tumor antigenic peptides translated from different open reading frames
JO  - J. Immunol.
PY  - 1998///
VL  - 161
SP  - 3596
EP  - 3606
ER  - 

TY  - JOUR
AU  - Robbins, P F
TI  - A mutated B-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
JO  - J. Exp. Med.
PY  - 1996///
VL  - 183
SP  - 1185
EP  - 1192
ER  - 

TY  - JOUR
AU  - Chiari, R
TI  - Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene
JO  - Cancer Res.
PY  - 1999///
VL  - 22
SP  - 5785
EP  - 5792
ER  - 

TY  - JOUR
AU  - Wolfel, T
TI  - A p16INK4A-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
JO  - Science
PY  - 1995///
VL  - 269
SP  - 1281
EP  - 1284
ER  - 

TY  - JOUR
AU  - Mandruzzato, S
AU  - Brasseur, F
AU  - Andry, G
TI  - A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
JO  - J. Exp. Med.
PY  - 1997///
VL  - 186
SP  - 785
EP  - 793
ER  - 

TY  - JOUR
AU  - Gueguen, M
AU  - Matard, J J
AU  - Gaugler, B
TI  - An antigen recognized by autologous CTLs on a human bladder carcinoma
JO  - J. Immunol.
PY  - 1998///
VL  - 160
SP  - 6188
EP  - 6194
ER  - 

TY  - JOUR
AU  - Brandle, D
AU  - Brasseur, F
AU  - Weynants, P
TI  - A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma
JO  - J. Exp. Med.
PY  - 1996///
VL  - 183
SP  - 2501
EP  - 2508
ER  - 

TY  - JOUR
AU  - Butterfield, L H
TI  - Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein
JO  - Cancer Res.
PY  - 1999///
VL  - 59
SP  - 3134
EP  - 3142
ER  - 

TY  - JOUR
AU  - Vonderheide, R H
AU  - Hahn, W C
AU  - Schultze, J L
AU  - Nadler, L M
TI  - The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
JO  - Immunity
PY  - 1999///
VL  - 10
SP  - 673
EP  - 679
ER  - 

TY  - JOUR
AU  - Vissers, J L
TI  - The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes
JO  - Cancer Res.
PY  - 1999///
VL  - 59
SP  - 5554
EP  - 5559
ER  - 

TY  - JOUR
AU  - Jerome, K R
TI  - Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
JO  - Cancer Res.
PY  - 1991///
VL  - 51
SP  - 2908
EP  - 2916
ER  - 

TY  - JOUR
AU  - Tsang, K Y
AU  - Zaremba, S
AU  - Nieroda, C A
TI  - Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
JO  - J. Natl Cancer Inst.
PY  - 1995///
VL  - 87
SP  - 982
EP  - 990
ER  - 

TY  - JOUR
AU  - Theobald, M B J
AU  - Dittmer, D
AU  - Levine, A J
AU  - Sherman, L A
TI  - Targeting p53 as a general tumor antigen
JO  - Proc. Natl Acad. Sci. USA
PY  - 1995///
VL  - 92
SP  - 11993
EP  - 11997
ER  - 

TY  - JOUR
AU  - Ioannides, C G
TI  - T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene
JO  - Cell Immunol.
PY  - 1993///
VL  - 151
SP  - 225
EP  - 234
ER  - 

TY  - JOUR
AU  - Li, K
TI  - Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and annexin II eluted from melanoma cells
JO  - Cancer Immunol. Immunother.
PY  - 1998///
VL  - 47
SP  - 32
EP  - 38
ER  - 

TY  - JOUR
AU  - Chaux, P
TI  - Identification of MAGE-3, epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
JO  - J. Exp. Med.
PY  - 1999///
VL  - 189
SP  - 767
EP  - 777
ER  - 

TY  - JOUR
AU  - Topalian, S L
TI  - Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene
JO  - Proc. Natl Acad. Sci. USA
PY  - 1994///
VL  - 91
SP  - 9461
EP  - 9465
ER  - 

TY  - JOUR
AU  - Zeng, G
TI  - Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
JO  - J. Immunol.
PY  - 2000///
VL  - 165
SP  - 1153
EP  - 1159
ER  - 

TY  - JOUR
AU  - Pieper, R
TI  - Biochemical identification of a mutated human melanoma antigen recognized by CD4+ T cells
JO  - J. Exp. Med.
PY  - 1999///
VL  - 189
SP  - 757
EP  - 766
ER  - 

TY  - JOUR
AU  - Wang, R -F
AU  - Wang, X
AU  - Rosenberg, S A
TI  - Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4+ T cells
JO  - J. Exp. Med.
PY  - 1999///
VL  - 189
SP  - 1659
EP  - 1667
ER  - 

